Sort   by:  
 Page size 
ProteomicsNeuroproteomics with Systems Biology: The proteomic landscape of adult human hypothalamus
The hypothalamus is an anatomically small, but functionally crucial region of the human brain. Normal hypothalamus functioning is central to the regulation of neuroendocrine and neurovegetative systems as well as modulation of chronobiology and behavioral aspects of the human body. Till date the hum...
ORGANISM(S): Homo sapiens (Human) 
2021-11-01 | PXD026879 | Pride
Hypothalamus Autophagy Proteomics Proteogenomics Post translational modifications Neuropeptides. Human brain Adult neurogenesis Orbitrap fusion 
ProteomicsProteogenomics of Candida tropicalis – an opportunistic pathogen
Candida tropicalis is an opportunistic pathogen which causes candidiasis in immune-compromised individuals. It is one of the members of the non-albicans group of Candida that are known to be azole resistant and is frequently seen in individuals being treated for cancers, HIV-infection and bone-marr...
ORGANISM(S): Candida tropicalis (Yeast) 
2017-05-08 | PXD001071 | Pride
Genome annotation Shotgun proteomics 
ProteomicsPhosphoproteomic analysis of Protein Phosphatase PfPPM2/PP2C mutant of Plasmodium falciparum 3D7
PfPPM2, a protein phosphatase, plays a key role in regulating both the asexual and sexual development of the human malaria parasite P. falciparum. To understand the mechanisms by which PfPPM2 influences this process, it was essential to identify its targets or substrates within the parasite. To achi...
ORGANISM(S): Plasmodium falciparum (isolate 3D7) 
2025-04-08 | PXD055390 | Pride
Phosphoproteomics Plasmodium falciparum Tmt labelling Orbitrap fusion. 
ProteomicsQuantitative proteomic and phosphoproteomic analysis of H37Ra and H37Rv strains of Mycobacterium tuberculosis
Mycobacterium tuberculosis, the causative agent of tuberculosis accounts for 1.5 million annual deaths worldwide. The two well-characterized strains of the parental H37 strain namely, H37Ra and H37Rv show different pathogenic phenotypes. In order to identify factors that are responsible for virulenc...
ORGANISM(S): Mycobacterium tuberculosis 
2017-05-08 | PXD004161 | Pride
Virulence attenuation Mycobacterium tuberculosis Phosphoproteomics 
MetabolomicsUntargeted metabolomics workshop report: quality control considerations from sample preparation to data analysis

The Metabolomics workshop on experimental and data analysis training for untargeted metabolomics was hosted by the Proteomics Society of India in December 2019. The Workshop included six tutorial lectures and hands-on data analysis training sessions presented by seven speakers. The tutorials and ...

2020-12-17 | MTBLS1301 | MetaboLights
ProteomicsGut Microbial Ecosystem Multiomics in Inflammatory Bowel Disease
Using multiple omics approaches to explore the effect of the gut microbial ecosytem on inflammatory bowel disease
ORGANISM(S): Environmental Samples <bacteria> (ncbitaxon:48479) 
2019-07-02 | MSV000084050 | MassIVE
UnknownAntibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy.
Not available
S-EPMC12782970 | biostudies-literature
ProteomicsGenetic aberrations in MAP kinase pathway play an important role in erlotinib resistance in head and neck cancer
Epidermal growth factor receptor (EGFR), a receptor tyrosine kinase is overexpressed in 90% of Head and neck squamous cell carcinoma (HNSCC) patients. Clinical trials with EGFR-targeted tyrosine kinase inhibitors such as erlotinib have shown a modest activity in HNSCC alternate mechanisms of resist...
ORGANISM(S): Homo sapiens (Human) 
2019-12-18 | PXD007785 | Pride
Head and neck cancer Mass spectrometry Signaling pathways Quantitative phosphoproteomics Egfr-tyrosine kinase inhibitor resistance 
ProteomicsSILAC-based quantitative tyrosine phosphoproteomic profiling identifies alternative therapeutic targets to erlotinib in head and neck squamous cell carcinoma
Epidermal growth factor receptor (EGFR), a receptor tyrosine kinase is overexpressed in 90% of Head and neck squamous cell carcinoma (HNSCC) patients. Clinical trials with EGFR-targeted tyrosine kinase inhibitors such as erlotinib have shown a modest activity in HNSCC alternate mechanisms of resist...
ORGANISM(S): Homo sapiens (Human) 
2022-10-13 | PXD007769 | Pride
Head and neck cancer Mass spectrometry Signaling pathways Quantitative proteomics Egfr-tyrosine kinase inhibitor resistance 
UnknownProteomics-based approach for differentiation of age-related macular degeneration sub-types.
Not available
S-EPMC7942106 | biostudies-literature
Sort   by:  
 Page size